Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Healius Limited (HLS) vs. Competitors

69 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AU:HLSHealius LimitedAUD 0.61AUD 439.34M-1.05-31.25%HoldUnlock the AU:HLS analyst price target with TipRanks PremiumAU:HLSUnlock the AU:HLS top-analyst price target with TipRanks Premium
AU:LDXLumos Diagnostics Holdings Ltd.AUD 0.07AUD 71.15M-7.27-57.65%Moderate BuyUnlock the AU:LDX analyst price target with TipRanks PremiumAU:HLS vs AU:LDXUnlock the AU:LDX top-analyst price target with TipRanks Premium
AU:SHLSonic Healthcare LimitedAUD 21.33AUD 10.54B17.43-0.74%HoldUnlock the AU:SHL analyst price target with TipRanks PremiumAU:HLS vs AU:SHLUnlock the AU:SHL top-analyst price target with TipRanks Premium
AU:IDXIntegral Diagnostics Ltd.AUD 1.66AUD 619.98M28.32-34.65%Moderate BuyUnlock the AU:IDX analyst price target with TipRanks PremiumAU:HLS vs AU:IDXUnlock the AU:IDX top-analyst price target with TipRanks Premium
AU:ACLAustralian Clinical Labs LtdAUD 3.35AUD 624.84M26.5026.42%HoldUnlock the AU:ACL analyst price target with TipRanks PremiumAU:HLS vs AU:ACLUnlock the AU:ACL top-analyst price target with TipRanks Premium
AU:MVFMonash IVF Group LtdAUD 0.76AUD 294.17M30.9927.97%Moderate BuyUnlock the AU:MVF analyst price target with TipRanks PremiumAU:HLS vs AU:MVFUnlock the AU:MVF top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AU:HLSHealius Limited0.60-0.33-35.64%
AU:LDXLumos Diagnostics Holdings Ltd.0.07-0.12-62.11%
AU:SHLSonic Healthcare Limited21.33-0.36-1.64%
AU:IDXIntegral Diagnostics Ltd.1.66-0.81-32.77%
AU:ACLAustralian Clinical Labs Ltd3.350.7227.33%
AU:MVFMonash IVF Group Ltd0.760.1626.25%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts